VION Biosciences acquires Echelon Biosciences

VION Biosciences has announced the acquisition of Echelon Biosciences, known for its supply of materials such as lipid-based excipients.

Aug 25, 2024 - 04:00

VION Biosciences acquires Echelon Biosciences

VION Biosciences has announced the acquisition of Echelon Biosciences, known for its supply of materials such as lipid-based excipients.

Read the original article

Tags:

Previous Article

Rafael Holdings and Cyclo Therapeutics enter merger deal

FDA approves updated mRNA vaccines for Covid-19

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

STAT+: Pharmalittle: Exec nominated to Biogen board is mother of outgoing director’s child; telehealth company pauses Wegovy ads amid shortages

STAT+: Pharmalittle: Exec nominated to Biogen board is ...

Jun 14, 2023

Opinion: I learned the hard way that U.S. airlines are not currently required to have EpiPens

Opinion: I learned the hard way that U.S. airlines are ...

Aug 1, 2023

Aquestive Therapeutics gets grant for enhanced pharmace...

Aug 23, 2024